Topic Editors

Prof. Dr. Marshall Vance Williams
1. Department of Cancer Biology and Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, USA
2. Institute for Behavioral Medicine Research, The Ohio State University College of Medicine, Columbus, OH 43210, USA
Department of Microbiology, Norfolk & Norwich University Hospitals NHS Foundation Trust, Norwich, UK

Epstein-Barr Virus Disease Mechanisms and Therapeutic Strategies

Abstract submission deadline
closed (30 January 2023)
Manuscript submission deadline
closed (30 April 2023)
Viewed by
963

Topic Information

Dear Colleagues,

Epstein–Barr virus (EBV) infects a significant percentage (>95%) of the population and establishes a persistent infection. However, most of these infections are asymptomatic. A small but significant number of EBV-positive patients develop a variety of lymphomas, including Burkitt lymphoma, diffuse large-cell B cell lymphoma, classical Hodgkin lymphoma and epithelial malignancies including nasopharyngeal carcinoma and gastric carcinoma. Furthermore, there is increasing evidence that EBV may be a trigger/driver for some autoimmune diseases, including multiple sclerosis, systemic lupus erythematosus, Sjogren’s syndrome and rheumatoid arthritis. Most studies have focused on the potential role of latency-associated gene products in these diseases, but there is accumulating evidence that the products of genes expressed during lytic or abortive-lytic activity may also be involved. This Topic is devoted to exploring the role of how molecules produced during lytic/abortive-lytic replication of EBV may contribute to modifying the host’s immune system in immunocompetent individuals and how the proteins may contribute to the disease process.

Prof. Dr. Marshall Vance Williams
Dr. Jonathan Kerr
Topic Editors

Keywords

  • Epstein–Barr virus
  • lytic replication
  • innate immunity
  • autoimmunity
  • new therapeutics approaches

Participating Journals

Journal Name Impact Factor CiteScore Launched Year First Decision (median) APC
Biomolecules
biomolecules
6.064 8.3 2011 16.6 Days 2300 CHF
International Journal of Molecular Sciences
ijms
6.208 7.8 2000 15.9 Days 2500 CHF
Pathogens
pathogens
4.531 5.1 2012 15.9 Days 2200 CHF
Vaccines
vaccines
4.961 7.0 2013 17.3 Days 2200 CHF
Viruses
viruses
5.818 7.1 2009 15.6 Days 2600 CHF

Preprints is a platform dedicated to making early versions of research outputs permanently available and citable. MDPI journals allow posting on preprint servers such as Preprints.org prior to publication. For more details about reprints, please visit https://www.preprints.org.

Published Papers

There is no accepted submissions to this Topic at this moment.
Back to TopTop